{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T10:10:34Z","timestamp":1783851034799,"version":"3.55.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Peptides"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1016\/j.peptides.2004.12.019","type":"journal-article","created":{"date-parts":[[2005,3,12]],"date-time":"2005-03-12T16:55:56Z","timestamp":1110646556000},"page":"827-836","source":"Crossref","is-referenced-by-count":42,"title":["Brain mast cells and therapeutic potential of vasoactive intestinal peptide in a Parkinson's disease model in rats: Brain microdialysis, behavior, and microscopy"],"prefix":"10.1016","volume":"26","author":[{"given":"Ne\u015fe","family":"Tun\u00e7el","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erol","family":"\u015eener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cem","family":"Cerit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut","family":"Karasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdevs","family":"G\u00fcrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varol","family":"\u015eahint\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cengiz","family":"Bay\u00e7u","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilek","family":"Ak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeynep","family":"Filiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.peptides.2004.12.019_bib1","first-page":"71","article-title":"Report on the XIII ICACI Montreux Switzerland on 17\u201323 October","volume":"10","author":"Aiuti","year":"1989","journal-title":"Immunol"},{"key":"10.1016\/j.peptides.2004.12.019_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/brain\/109.1.143","article-title":"Neuropeptides and dopamine in the marmoset. Effect of treatment with 1-methyl-4-phenyl-1,2,36 tetrahydropyridine (MPTP): an animal model for Parkinson's disease","volume":"109","author":"Allen","year":"1986","journal-title":"Brain"},{"key":"10.1016\/j.peptides.2004.12.019_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1381612013398383","article-title":"Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives","volume":"7","author":"Aloe","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.peptides.2004.12.019_bib4","doi-asserted-by":"crossref","first-page":"11347","DOI":"10.1073\/pnas.89.23.11347","article-title":"Brain-derived neurotrophic factor augments rotational behavior and nigrostriatal dopamine turnover in vivo","volume":"89","author":"Altar","year":"1992","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib5","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0304-4165(78)90096-X","article-title":"Modulation of adenylate cyclase activity by sulfated glycosaminoglycans. II. Effects of mucopolysaccharides and dextran sulfate on the activity of adenylate cyclase derived from various tissues","volume":"544","author":"Aterdam","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.peptides.2004.12.019_bib6","first-page":"293","article-title":"Mast cells in the cerebral circulation. Characterization and possible function","volume":"vol. II","author":"Aubineau","year":"1989"},{"issue":"4","key":"10.1016\/j.peptides.2004.12.019_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/01.STR.27.4.743","article-title":"Effect of age and sex on N-methyl-d-aspartate antagonist-induced neuronal necrosis in rats","volume":"27","author":"Auer","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.peptides.2004.12.019_bib8","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1095-6433(98)00027-0","article-title":"Ovarian, uterine and brain mast cell in female rats: cyclic changes and contribution to tissue histamine","volume":"120","author":"Ayd\u0131n","year":"1998","journal-title":"Comp Biochem Physiol"},{"key":"10.1016\/j.peptides.2004.12.019_bib9","first-page":"213","article-title":"Mast cell-nerve interactions","volume":"15","author":"Bauer","year":"2000","journal-title":"News Physiol Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/S0306-4522(99)00504-7","article-title":"Long-term superior cervical sympathectomy induces mast cell hyperplasia and increases histamine and serotonin content in the rat dura mater","volume":"96","author":"Bergerot","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2004.12.019_bib11","first-page":"L151","article-title":"Vasoactive intestinal peptide prevents lung injury due to xanthine\/xantihine oxidase","volume":"259","author":"Berisha","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/j.peptides.2004.12.019_bib12","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1006\/exnr.1997.6436","article-title":"Intracerebroventricular glial cell line-derived neurotrophic factor improves motor function and supports nigrostriatal dopamine neurons in bilaterally 6-hydroxydopamine lesioned rats","volume":"145","author":"Bowenkamp","year":"1997","journal-title":"Exp Neurol"},{"key":"10.1016\/j.peptides.2004.12.019_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/jnr.490250316","article-title":"Vasoactive intestinal peptide: a neurotrophic releasing agent and an astroglial mitogen","volume":"25","author":"Brenneman","year":"1990","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib14","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1749-6632.1997.tb46155.x","article-title":"Identity of neurotrophic molecules released from astroglia by vasoactive intestinal peptide","volume":"814","author":"Brenneman","year":"1997","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1006\/mcne.2000.0840","article-title":"Neuronal release of vasoactive intestinal peptide is important to astrocytic protection of neurons from glutamate toxicity","volume":"15","author":"Brown","year":"2000","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.peptides.2004.12.019_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.nbd.2003.10.003","article-title":"Plasma and CSF markers of oxidative stress are increased in Parkinson's disease and influenced by antiparkinsonian medication","volume":"15","author":"Buhmann","year":"2004","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.peptides.2004.12.019_bib17","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.urology.2003.08.010","article-title":"Protective effect of vasoactive intestinal peptide on testicular torsion-detorsion injury: association with heparin-containing mast cells","volume":"63","author":"Can","year":"2004","journal-title":"Urology"},{"key":"10.1016\/j.peptides.2004.12.019_bib18","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/275661a0","article-title":"Release of vasoactive intestinal polypeptide in mast cells by histamine liberator","volume":"275","author":"Cutz","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2004.12.019_bib19","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1042\/bj2800791","article-title":"Heparin and other polyanions uncouple alpha 1-adrenoceptors from G-proteins","volume":"280","author":"Dasso","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.peptides.2004.12.019_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbr.2003.10.009","article-title":"Behavioral sensitization to different dopamine agonists in a parkinsonian rodent model of drug-induced dyskinesias","volume":"152","author":"Delfino","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib21","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.4049\/jimmunol.162.2.1200","article-title":"Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6","volume":"162","author":"Delgado","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.peptides.2004.12.019_bib22","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s00109-001-0291-5","article-title":"Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune disease","volume":"80","author":"Delgado","year":"2002","journal-title":"J Mol Med"},{"key":"10.1016\/j.peptides.2004.12.019_bib23","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1096\/fj.02-0248fje","article-title":"Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide promote in vivo generation of memory Th2 cells","volume":"16","author":"Delgado","year":"2002","journal-title":"FASEB J"},{"key":"10.1016\/j.peptides.2004.12.019_bib24","doi-asserted-by":"crossref","first-page":"U568","DOI":"10.1096\/fj.02-0799fje","article-title":"Neuroprotective effect of vasoactive intestinal peptide (VIP) in a mouse model of Parkinson's disease by blocking microglial activation","volume":"17","author":"Delgado","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.peptides.2004.12.019_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1096\/fj.02-1029fje","article-title":"Vasoactive intestinal peptide prevents activated microglia-induced neurodegeneration under inflammatory conditions: potential therapeutic role in brain trauma","volume":"17","author":"Delgado","year":"2003","journal-title":"FASEB J"},{"key":"10.1016\/j.peptides.2004.12.019_bib26","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0196-9781(02)00068-2","article-title":"Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases","volume":"23","author":"Diaz-Nido","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib27","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1046\/j.1468-2982.1990.1005221.x","article-title":"Cluster headache; ultrastructural evidence for mast cell degranulation and interaction with nerve fibres in human temporal artery","volume":"10","author":"Dimitriadou","year":"1990","journal-title":"Cephalalgia"},{"key":"10.1016\/j.peptides.2004.12.019_bib28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-3806(96)00127-7","article-title":"Rat cerebral mast cells undergo phenotypic changes during development.","volume":"97","author":"Dimitriadou","year":"1996","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib29","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0196-9781(03)00059-7","article-title":"Passage of vasoactive intestinal peptide across the blood-brain barrier","volume":"24","author":"Dogrukol-Ak","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib30","first-page":"5","article-title":"New insights into \u201cthe riddle of the mast cells\u201d: microenvironmental regulation of mast cell development and phenotypic heterogeneity","volume":"62","author":"Galli","year":"1990","journal-title":"Lab Invest"},{"key":"10.1016\/j.peptides.2004.12.019_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1080\/10298420290015881","article-title":"Neuroprotecttion in Parkinson's disease; a commentary","volume":"4","author":"Gatto","year":"2002","journal-title":"Neurotox Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2174\/1381612013398374","article-title":"Immunology of VIP: a review and therapeutical perspectives","volume":"7","author":"Gomariz","year":"2001","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.peptides.2004.12.019_bib33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/(SICI)1097-4695(199709)33:3<329::AID-NEU10>3.0.CO;2-A","article-title":"Protection against developmental retardation in apolipoprotein E-deficient mice by a fatty neuropeptide: implications for early treatment of Alzheimer's disease","volume":"33","author":"Gozes","year":"1997","journal-title":"J Neurobiol"},{"key":"10.1016\/j.peptides.2004.12.019_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1749-6632.1999.tb07883.x","article-title":"VIP neuroprotection against excitotoxic lesions of the developing mouse brain","volume":"897","author":"Gressens","year":"1999","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib35","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0945-053X(00)00137-2","article-title":"Proteoglycans in the nervous system-the quest for functional roles in vivo","volume":"20","author":"Hartmann","year":"2001","journal-title":"Matrix Biol"},{"key":"10.1016\/j.peptides.2004.12.019_bib36","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0196-9781(02)00137-7","article-title":"Vasoactive intestinal peptide regulation of nerve growth factor in the embryonic mouse","volume":"23","author":"Hill","year":"2002","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib37","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0196-9781(88)90266-5","article-title":"Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain","volume":"9","author":"Itoh","year":"1988","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib38","first-page":"952","article-title":"Protective role of intracoronary vasoactive intestinal peptide in ischemic and reperfused myocardium","volume":"268","author":"Kalfin","year":"1994","journal-title":"J Pharm Exp Ther"},{"key":"10.1016\/j.peptides.2004.12.019_bib39","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1523\/JNEUROSCI.17-17-06807.1997","article-title":"The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease","volume":"17","author":"Kreiss","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2004.12.019_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000236383","article-title":"Inhibitory effects of vasoactive intestinal peptide on superoxide anion formation by N-formyl-methionyl-leucyl-phenylalanine-activated inflammatory cells in vitro","volume":"100","author":"Kurosawa","year":"1993","journal-title":"Arch Allergy Immunol"},{"key":"10.1016\/j.peptides.2004.12.019_bib41","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/0306-4522(95)00571-4","article-title":"Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat","volume":"72","author":"Lee","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2004.12.019_bib42","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1073\/pnas.91.9.3739","article-title":"Mast cells synthesize, store, and release nerve growth factor","volume":"91","author":"Leon","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.peptides.2004.12.019_bib43","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jneuroim.2003.09.004","article-title":"Ultrastructural evidence of brain mast cell activation without degranulation in monkey experimental allergic encephalomyelitis","volume":"145","author":"Letourneau","year":"2003","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.peptides.2004.12.019_bib44","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1523\/JNEUROSCI.15-12-07810.1995","article-title":"Intrastriatal implantation of fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevents degeneration of dopaminergic neurons in a rat model of parkinson's disease","volume":"15","author":"Levivier","year":"1995","journal-title":"J Neurosci"},{"key":"10.1016\/j.peptides.2004.12.019_bib45","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1006\/exnr.1993.1181","article-title":"The therapeutic potential of neurotrophic factors in the treatment of Parkinson's disease","volume":"124","author":"Lindsay","year":"1993","journal-title":"Exp Neurol"},{"key":"10.1016\/j.peptides.2004.12.019_bib46","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01376517-199702000-00004","article-title":"Pathophysiology and management of idiopathic Parkinson's disease","volume":"29","author":"Lusis","year":"1997","journal-title":"J Neurosci Nurs"},{"key":"10.1016\/j.peptides.2004.12.019_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/S0197-0186(03)00170-0","article-title":"Acetaminophen and aspirin inhibit superoxide anion generation and lipid peroxidation, and protect against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats","volume":"44","author":"Maharaj","year":"2004","journal-title":"Neurochem Int"},{"key":"10.1016\/j.peptides.2004.12.019_bib48","doi-asserted-by":"crossref","first-page":"729","DOI":"10.2165\/00023210-200317100-00004","article-title":"Neuroprotective strategies in Parkinson's disease\u2014an update on progress","volume":"17","author":"Mandel","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.peptides.2004.12.019_bib49","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0014-4886(03)00107-9","article-title":"Effect of acute and chronic administration of U50,488 a kappa opioid receptor agonist, in 6-OHDA-lesioned rats chronically treated with levodopa","volume":"183","author":"Marin","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.peptides.2004.12.019_bib50","doi-asserted-by":"crossref","first-page":"377","DOI":"10.2165\/00002512-200320050-00006","article-title":"Glutamate receptors and Parkinson's disease\u2014opportunities for intervention","volume":"20","author":"Marino","year":"2003","journal-title":"Drug Aging"},{"key":"10.1016\/j.peptides.2004.12.019_bib51","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/0006-8993(96)00686-5","article-title":"A attenuates degeneration of dopaminergic neurons induced by 6-hydroxydopamine in the mouse brain","volume":"733","author":"Matsuura","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib52","doi-asserted-by":"crossref","first-page":"15371","DOI":"10.1016\/S0021-9258(18)55404-1","article-title":"Vasoactive intestinal peptide, a singlet oxygen quencher","volume":"265","author":"Misra","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1016\/j.peptides.2004.12.019_bib53","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(00)01275-1","article-title":"Increase in level of tumor necrosis factor-\u03b1 in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506","volume":"289","author":"Mogi","year":"2000","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2004.12.019_bib54","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0196-9781(02)00290-5","article-title":"VIP as a trophic factor in the CNS and cancer cells","volume":"24","author":"Moody","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib55","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1046\/j.1471-4159.2000.0742305.x","article-title":"Preferential resistance of dopaminergic neurons to the toxicity of glutathione depletion is independent of cellular glutathione peroxidase and is mediated by tetrahydrobiopterin","volume":"74","author":"Nakamura","year":"2000","journal-title":"J Neurochem"},{"key":"10.1016\/j.peptides.2004.12.019_bib56","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000109568","article-title":"Heparin inhibits melatonin binding and signal transduction in chick brain","volume":"3","author":"Niles","year":"1994","journal-title":"Biol Signals"},{"key":"10.1016\/j.peptides.2004.12.019_bib57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF01345239","article-title":"Adenosine A(2A) receptors inhibit the conductance of NMDA receptor channels in rat neostriatal neurons","volume":"14","author":"Norenberg","year":"1998","journal-title":"Amino Acids"},{"key":"10.1016\/j.peptides.2004.12.019_bib58","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0006-8993(99)02375-6","article-title":"Vasoactive intestinal peptide (VIP) prevents neurotoxicity in neuronal cultures: relevance to neuroprotection in Parkinson's disease","volume":"854","author":"Offen","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib59","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0304-3940(94)90603-3","article-title":"Differential effects of chronic L-DOPA treatment on lipid peroxidation in the mouse brain with or without pretreatment with 6-hydroxydopamine","volume":"171","author":"Ogawa","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.peptides.2004.12.019_bib60","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S0024-3205(97)00411-6","article-title":"Impairment of muscarinic stimulation of adenylyl cyclase by heparin in rat olfactory bulb","volume":"61","author":"Olianas","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib61","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0006-8993(85)90691-2","article-title":"The regional distribution of receptors for vasoactive intestinal polypeptide (VIP) in the rat central nervous system","volume":"330","author":"Olsen","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib62","series-title":"The rat brain in stereotaxic coordinates","author":"Paxinos","year":"1997"},{"key":"10.1016\/j.peptides.2004.12.019_bib63","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/343564a0","article-title":"Vasoactive intestinal peptide regulates mitosis, differentiation and survival of cultured sympathetic neuroblasts","volume":"343","author":"Pincus","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.peptides.2004.12.019_bib64","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bbr.2003.09.007","article-title":"Pituitary adenylate cyclase activating polypeptide protects dopaminergic neurons and improves behavioral deficits in a rat model of Parkinson's disease","volume":"151","author":"Reglodi","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib65","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.mcn.2003.10.009","article-title":"NG2 proteoglycan expression in the peripheral nervous system: upregulation following injury and comparison with CNS lesions","volume":"25","author":"Rezajooi","year":"2004","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/j.peptides.2004.12.019_bib66","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0378-4347(00)82297-5","article-title":"Fully automated high-performance liquid chromatographic assay for the analysis of free catecholamines in urine","volume":"530","author":"Said","year":"1990","journal-title":"J Chromatogr"},{"key":"10.1016\/j.peptides.2004.12.019_bib67","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1432-1033.1972.tb01903.x","article-title":"Isolation from porcine intestinal wall of vasoactive octacosapeptide related to secretin and to glucagons","volume":"28","author":"Said","year":"1972","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.peptides.2004.12.019_bib68","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1126\/science.1273576","article-title":"Vasoactive intestinal peptide: abundant immunoreactivity in neural cell lines and normal nervous tissues","volume":"192","author":"Said","year":"1976","journal-title":"Science"},{"key":"10.1016\/j.peptides.2004.12.019_bib69","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/BF03348097","article-title":"Vasoactive intestinal peptide","volume":"9","author":"Said","year":"1986","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/j.peptides.2004.12.019_bib70","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0306-4522(95)00021-A","article-title":"N-Methyl-d-aspartate receptors outside the central nervous system: activation causes acute lung injury that is mediated by nitric oxide synthesis and prevented by vasoactive intestinal peptide","volume":"65","author":"Said","year":"1995","journal-title":"Neuroscience"},{"key":"10.1016\/j.peptides.2004.12.019_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0167-0115(00)00174-9","article-title":"Pathways of inflammation and cell death in the lung: modulation by vasoactive intestinal peptide","volume":"93","author":"Said","year":"2000","journal-title":"Regul Pept"},{"key":"10.1016\/j.peptides.2004.12.019_bib72","first-page":"A645","article-title":"Vasoactive intestinal peptide (VIP) inhibits superoxide anion release from rat alveolar macrophages","volume":"141","author":"Sakakibara","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.peptides.2004.12.019_bib73","series-title":"Central nervous system diseases, innovative animal models from lab to clinic","first-page":"131","article-title":"Intervention strategics for degeneration of dopamine neurons in parkinsonism","author":"Schallert","year":"2000"},{"key":"10.1016\/j.peptides.2004.12.019_bib74","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1084\/jem.191.5.813","article-title":"Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis","volume":"191","author":"Secor","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.peptides.2004.12.019_bib75","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0166-2236(96)81863-7","article-title":"Mast cells in the brain: evidence and functional significance","volume":"19","author":"Silver","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.peptides.2004.12.019_bib76","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1385\/JMN:15:3:137","article-title":"VIP and peptides related to activity-dependent neurotropic factor protect PC12 cells against oxidative stress","volume":"15","author":"Steingart","year":"2000","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.peptides.2004.12.019_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0014-4886(91)90080-V","article-title":"Decreased levels of [Met]enkephalin, neuropeptide Y, substance P, and vasoactive intestinal peptide in parkinsonian adrenal medulla","volume":"114","author":"Stoddard","year":"1991","journal-title":"Exp Neurol"},{"key":"10.1016\/j.peptides.2004.12.019_bib78","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/0024-3205(90)90129-F","article-title":"Mast cells: the immune gate to the brain","volume":"46","author":"Theoharides","year":"1990","journal-title":"Life Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib79","first-page":"1","article-title":"The mast cell: a neuroimmunoendocrine master player","volume":"18","author":"Theoharides","year":"1996","journal-title":"Int J Tissue React"},{"key":"10.1016\/j.peptides.2004.12.019_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1159\/000138826","article-title":"Mast cell degranulation in hemorrhagic shock in rats and the effects of vasoactive intestinal peptide, aprotinin and H1 and H2-receptor blockers on degranulation","volume":"43","author":"T\u0131k\u0131z","year":"1991","journal-title":"Pharmacology"},{"key":"10.1016\/j.peptides.2004.12.019_bib81","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/sj.bjp.0704412","article-title":"Effects of sepsis on mast cells in rat dura mater: influence of L-NAME and VIP","volume":"134","author":"T\u00f6re","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.peptides.2004.12.019_bib82","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1749-6632.1996.tb17509.x","article-title":"Protection of rat retina from ischemia\u2013reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid","volume":"805","author":"Tun\u00e7el","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib83","first-page":"817","article-title":"The effect of vasoactive intestinal peptide (VIP) on mast cell invasion\/degranulation in testicular interstitium of immobilized+cold stressed and beta endorphin-treated rats","volume":"17","author":"Tun\u00e7el","year":"1996","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1749-6632.1998.tb11191.x","article-title":"The protective effect of vasoactive intestinal peptide (VIP) on stress-induced gastric ulceration in rats","volume":"865","author":"Tun\u00e7el","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib85","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/j.1749-6632.1998.tb11241.x","article-title":"The effect of vasoactive intestinal peptide (VIP) inhibition of nitric oxide synthase on survival rate in rats exposed to endotoxin shock","volume":"865","author":"Tun\u00e7el","year":"1998","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.peptides.2004.12.019_bib86","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0196-9781(99)00177-1","article-title":"Vasoactive intestinal peptide inhibits degranulation and changes granular content of mast cells: a potential therapeutic strategy in controlling septic shock","volume":"21","author":"Tun\u00e7el","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib87","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-201X.1971.tb11000.x","article-title":"Post synaptic supersensitivity after 6-Hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system","volume":"367","author":"Ungerstedt","year":"1971","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/j.peptides.2004.12.019_bib88","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0196-9781(95)00055-O","article-title":"The effect of vasoactive intestinal peptide (VIP) on superoxide dismutase and catalase activities in renal tissues of rats exposed to hemorrhagic ischemia\u2013reperfusion","volume":"16","author":"Uzuner","year":"1995","journal-title":"Peptides"},{"key":"10.1016\/j.peptides.2004.12.019_bib89","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S0952-7915(00)00154-0","article-title":"Roles of mast cells and basophils in innate and acquired immunity","volume":"12","author":"Wedemeyer","year":"2000","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.peptides.2004.12.019_bib90","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1042\/bj2490857","article-title":"Heparin uncouples alpha 2-adrenoceptors from the Gi-protein in membranes of human platelets","volume":"249","author":"Willuweit","year":"1988","journal-title":"Biochem J"},{"key":"10.1016\/j.peptides.2004.12.019_bib91","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1080\/13550280290100905","article-title":"Glial cell response: a pathogenic factor in Parkinson's disease","volume":"8","author":"Wu","year":"2002","journal-title":"J Neurovirol"},{"issue":"3","key":"10.1016\/j.peptides.2004.12.019_bib92","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0301-0082(00)00006-X","article-title":"Implication of cystein proteases calpain, cathepsin and caspase in ischemic neuronal death of primates","volume":"62","author":"Yamashima","year":"2000","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.peptides.2004.12.019_bib93","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0006-8993(99)01935-6","article-title":"Morphological, immunohistochemical and quantitative studies of murine brain mast cells after mating.","volume":"846","author":"Yang","year":"1999","journal-title":"Brain Res"},{"key":"10.1016\/j.peptides.2004.12.019_bib94","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1046\/j.1529-8027.2002.02018.x","article-title":"Local administration of vasoactive intestinal peptide after nerve transection accelerates early myelination and growth of regenerating axons","volume":"7","author":"Zhang","year":"2002","journal-title":"J Peripher Nerv Syst"}],"container-title":["Peptides"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105000458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196978105000458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T16:49:49Z","timestamp":1683046189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196978105000458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0196978105000458"],"URL":"https:\/\/doi.org\/10.1016\/j.peptides.2004.12.019","relation":{},"ISSN":["0196-9781"],"issn-type":[{"value":"0196-9781","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}